期刊文献+

应用ROC曲线选择终末期肾病患者开始透析时机

Application of receiver operating charasteristic (ROC) curve in determing the occasion of initiation of dialysis in end stage senal disease
下载PDF
导出
摘要 目的应用ROC工作曲线选择终末期肾病(ESRD)患者开始血液透析时残余肾功能水平的界值,探讨其在ESRD患者的应用价值。方法回顾分析我院血液透析中心2001年6月至2006年6月开始第1次血液透析的146例ESRD患者的临床资料,同期获得血清C反应蛋白(SCRP)和肾功能检查等数据。采用ROC工作曲线选择最佳开始透析时机。结果①SCRP浓度与肾功能水平呈负相关;②选择肾小球滤过率(GFR)8.5ml/min时,诊断的灵敏度为88.9%,特异性为89.5%,准确性为88.3%。结论慢性肾衰竭患者SCRP水平增高;当肾功能下降到一定水平后会引起SCRP明显升高,应用ROC曲线选择GFR8.5ml/min具有较高的灵敏度、特异性;此法对制定科学的开始血液透析时肾功能标准具有重要的临床意义。 Objective To study the out-off value of glomerular filtration rate (GFR) of ESRD patients at the initiation of hemodialysis by ROC cure. Method serum c-reactive protein(SCRP), creatinine, blood urea nitrogen and other einical and laboratory data of all 146 ESRD in-patients who initiated their first hemodialysis treatment at blood purification center in our hospital during June of 2001 to June of 2006 were invesfigateel retrospectively. The best cut-off level of GFR was based on the receiver operating characteristics (ROC) curve. Results (1)In general, there was inverse linear correlation between SCRP and GFR(r = - 0. 648, P = 0. 000). (2)The cut-off value of GFR was 8. 5 ml/min. The sensitivity, specificity, accuracy were 88. 9%, 89. 5%, 88.3%, respectively. Conclusions The SCRP level increases in patients with chronic renal failure, and increases significantly when residual renal function fal.l.s bel.ow certain level.. 8. 5 ml./min as the cut-off val.ue pessesses higher sensitivity and specificity. It has important clinical significance for establishing a scientific criterion for nesidual nenalfunchin during initiating hemodialysis.
出处 《临床肾脏病杂志》 2007年第3期119-121,共3页 Journal Of Clinical Nephrology
关键词 肾功能衰竭 慢性 C反应蛋白 血液透析 ROC工作曲线 Failure, chronic C-reactive protein Hemodialys Receiver operating characteristics curve (ROC)
  • 相关文献

参考文献8

二级参考文献26

  • 1吕伯东,胡青,马寅峰,杨克冰,张士更,赵晓黎,张清芳,许凌宇,王寅,朱琮.新型光量子对血透患者慢性炎症反应状态的干预作用[J].中国中西医结合肾病杂志,2004,5(10):581-582. 被引量:14
  • 2戴振华,李晓玫,王海燕.白细胞介素-10对大鼠肾小球系膜细胞炎症效应的拮抗作用[J].中华医学杂志,1996,76(6):407-410. 被引量:14
  • 3Bergstrom J, Lindholm B, Lacson E Jr,et al.What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients?Semin Dial,2000,13:163-175.
  • 4Arici M, Walls J.End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?Kidney Int,2001,59:407-414.
  • 5Hou FF, Miyata T, Boyce J,et al.beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis.Kidney Int,2001,59:990-1002.
  • 6Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease.Am J Kidney Dis,1998,32(5 Suppl 3):S112-S119.
  • 7Kaysen GA. C-reactive protein: a story half told.Semin Dial,2000,13:143-146.
  • 8Craven TE, Ryu JE, Espeland MA, et al.Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study.Circulation,1990,82:1230-1242.
  • 9Moustapha A, Naso A, Nahlawi M,et al.Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.Circulation,1998,97:138-141.
  • 10Massy ZA, Ceballos I, Chadefaux-Vekemens B, et al. Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients. Kidney Int,2001,59 (Suppl 78): S243-S245.

共引文献227

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部